Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244803 · ClinicalTrials.gov registry record
Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 101
- Enrollment target
NCT00244803: Completed study, sponsored by Johns Hopkins University.
NCT00244803 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00244803 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-05 |
What the finished NCT00244803 record still lists
NCT00244803 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00244803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00244803 about?
NCT00244803 is a clinical study titled "Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)". The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
What is the current status of trial NCT00244803?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2005-01. Estimated completion is 2007-05.
Who is sponsoring clinical trial NCT00244803?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia